<DOC>
	<DOCNO>NCT02163642</DOCNO>
	<brief_summary>The purpose study demonstrate 1 ) secretion mucin , antimicrobial peptide Toll-like receptor alter certain patient non-CF bronchiectasis , make susceptible infect potentially pathogenic bacteria ( PPB ) ; 2 ) electronic nose able detect pattern specific Volatile Organic Compounds ( VOC ) patient non-CF bronchiectasis colonize PPB .</brief_summary>
	<brief_title>Role Innate Immunity Non-Cystic Fibrosis Bronchiectasis</brief_title>
	<detailed_description>Prospective , observational study , include 50 patient non-CF bronchiectasis follow period 12 month . A follow control perform every three month patient , consist medical record , lung function test , blood serum collection , sputum analysis culture , collection exhale air analysis use electronic nose . These test also repeat whenever patient exacerbation . At begin end study , high resolution chest CT perform .</detailed_description>
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Diagnosis non CF bronchiectasis base least 1 lobe bronchial dilatation compatible clinical symptom cough , sputum production respiratory infection . Signed informed consent . Presence exacerbation last 4 week . Antibiotic treatment last 4 week Use oral corticosteroid last 4 week Concomitant terminal illness . Current cigarette smoking Active allergic bronchopulmonary aspergillosis Diagnosis tuberculosis active nontuberculous Mycobacterial infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bronchiectasis</keyword>
	<keyword>Immunity</keyword>
</DOC>